Status:

COMPLETED

B3 Buddy for Securing Urinary Drainage Bag to Patient While Walking

Lead Sponsor:

Ohio State University Comprehensive Cancer Center

Conditions:

Urinary System Disorder

Eligibility:

All Genders

Phase:

NA

Brief Summary

This clinical trial tests how well the Bag Below Bladder (B3) Buddy device works in securing urinary drainage bags while walking. Keeping a urinary drainage bag below the bladder is the standard of ca...

Detailed Description

PRIMARY OBJECTIVES: I. To evaluate the acceptability of the B3 Buddy, from the patient's perspective. II. To evaluate the usability of the B3 Buddy, from the clinician's perspective. OUTLINE: Patie...

Eligibility Criteria

Inclusion

  • PATIENT PARTICIPANT: Must be English-speaking
  • PATIENT PARTICIPANT: Able to comprehend and agree to consent
  • PATIENT PARTICIPANT: Able to read and complete the Acceptability of Implementation Measure (AIM) survey
  • PATIENT PARTICIPANT: Be willing to participate using the B3 Buddy device
  • PATIENT PARTICIPANT: Have an indwelling urinary catheter or urostomy device connected to a drainage bag
  • PATIENT PARTICIPANT: Have no restrictions in ambulation
  • CLINICIAN PARTICIPANT: Must be English-speaking
  • CLINICIAN PARTICIPANT: Able to comprehend and agree to consent
  • CLINICIAN PARTICIPANT: Able to read and complete the System Usability Scale (SUS) survey
  • CLINICIAN PARTICIPANT: Be willing to participate using the B3 Buddy device
  • CLINICIAN PARTICIPANT: Have a professional role in assisting patients in ambulation in normal workday activities

Exclusion

  • Those patient participants that have more than one urinary-like drainage bags will be excluded. This exclusion is due to the limited prototype samples available to the research team. Limiting one device for one patient with multiple drainage bags may not allow for accurate assessment of the B3 Buddy device

Key Trial Info

Start Date :

July 27 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 17 2023

Estimated Enrollment :

41 Patients enrolled

Trial Details

Trial ID

NCT06571058

Start Date

July 27 2023

End Date

November 17 2023

Last Update

April 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Ohio State University Comprehensive Cancer Center

Columbus, Ohio, United States, 43210